Researchers have identified a potential link between gut bacteria and early signs of dementia, suggesting that analysis of microbial and chemical markers in the digestive system could aid in diagnosis and monitoring of cognitive decline. The study, led by Professor Paul Morgan at Cardiff University, focused on older adults, primarily couples in which one partner had mild cognitive impairment (MCI) while the other did not.

Using artificial intelligence to analyze fecal samples from 35 participants, the researchers found that individuals with MCI exhibited distinct differences in gut bacteria and chemical compounds compared to those without cognitive impairment. Specifically, those with MCI showed significantly higher levels of the bacterium Izemoplasmatales spp. and the amino acid proline, along with reduced amounts of Ruminococcus spp., Lachnospira spp., and fumaric acid. These bacteria have previously been associated with brain health.

To validate their findings, the team also studied an independent group of people with mild cognitive impairment over a one-year period. They observed that participants whose initial gut profiles included elevated levels of Bilophila spp. and certain chemicals—arginine, aspartic acid, and hypoxanthine—and lower concentrations of Coprococcus spp. experienced more rapid declines in memory and thinking abilities.

Co-author Dr. You Zhou highlighted the potential of these gut-based biomarkers as "simple, non-invasive tests" that might support earlier diagnosis of cognitive disorders. Professor Julian Marchesi, from Imperial College London and also part of the research team, noted that examining the relationship between gut microbes and brain function helps create a more comprehensive understanding of early changes in dementia.

The study, published in the journal MedComm, contributes to ongoing efforts to enhance early detection of dementia, a condition that causes approximately 76,000 deaths annually in Britain. This work aligns with broader initiatives, such as a campaign led by the Alzheimer’s Society and others, aiming to improve awareness, diagnosis, research, and care for those affected.

The researchers emphasize that additional studies are required involving larger and more diverse populations to explore how factors such as diet, lifestyle, ethnicity, environment, and genetic predisposition may influence gut microbiota and cognitive health. Such efforts could clarify the role the gut-brain connection plays in the development and progression of neurodegenerative conditions.